SMP-028 Inhaled Allergen Challenge Study

• Research type

  Research Study

• Full title

  An exploratory, randomised, double-blind, placebo controlled, 14 day, two-way crossover, Inhaled Allergen Challenge (IAC) study to evaluate the effects of SMP-028 in subjects with mild to moderate asthma.

• IRAS ID

  30088

• Contact name

  Brian Leaker

• Contact email

  brian.leaker@heartlungcentre.com

• Sponsor organisation

  Dainippon Sumitomo Pharma Europe Ltd

• Eudract number

  2009-012675-10

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• Research summary

  Research Summary not published at request of researcher

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  09/H0720/109

• Date of REC Opinion

  1 Oct 2009

• REC opinion

  Further Information Favourable Opinion